MTOR and arthritic joint disease: IL-1β induces inflammation, mitochondrial dysfunction and chondrocyte degeneration, while Sirt3 in arthritis treatment can ameliorate arthritis severity and joint damage through inhibition of the PI3K/Akt/mTOR pathway [85].